VistaGen Therapeutics Announces Pricing of Underwritten Public Offering
VistaGen Therapeutics Announces Pricing of Underwritten Public Offering VistaGen Therapeutics Announces Pricing of Underwritten Public Offering SOUTH SAN FRANCISCO, Calif., Dec. 18, 2020 — VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced the pricing of its underwritten public offering consisting of 63,000,000 shares of its common stock at an offering price of $0.92 per s...
Source: globalbankingandfinance.com